1776 |
130-100-135 |
Anti-Fibroblast-FITC, human 30 tests |
set |
1775 |
130-100-134 |
Anti-Fibroblast-FITC, human |
set |
1774 |
130-100-133 |
Anti-Fibroblast-APC, human 30 tests |
set |
1773 |
130-100-132 |
Anti-Fibroblast-APC, human |
set |
1772 |
130-100-131 |
CD158b2 (KIR2DL3)-APC, human |
set |
1771 |
130-100-130 |
CD158b2 (KIR2DL3)-APC, human 30 tests |
set |
1770 |
130-100-127 |
CD158b2 (KIR2DL3)-Biotin, human |
set |
1769 |
130-100-126 |
CD158b2 (KIR2DL3)-Biotin, human 30 tests |
set |
1768 |
130-100-122 |
CD158b2 (KIR2DL3)-PE, human 30 tests |
set |
1767 |
130-100-121 |
CD158b2 (KIR2DL3)-PE, human |
set |
1766 |
130-100-115 |
CD229-APC, human |
set |
1765 |
130-100-114 |
CD229-APC, human 30 tests |
set |
1764 |
130-100-113 |
CD229-PE, human |
set |
1763 |
130-100-112 |
CD229-PE, human 30 tests |
set |
1762 |
130-100-109 |
ODN 2395 Control (ODN 5328) 1mg |
set |
1761 |
130-100-108 |
ODN 2216 Control (ODN 2243) 1mg |
set |
1760 |
130-100-107 |
ODN 2006 Control (ODN 2137) 200µg |
set |
1759 |
130-100-106 |
ODN 2006 200µg |
set |
1758 |
130-100-105 |
ODN 2006 1mg |
set |
1757 |
130-100-104 |
ODN 1982 (B-class Control) 200µg |
set |